Okami Medical’s Embolization Platform Expands With Clearance of Sendero Max Catheter

March 24, 2025—Okami Medical announced its Sendero Max delivery catheter has received 510(k) clearance from the FDA. The Sendero Max catheter joins the Sendero microcatheter and Lobo occluders in the company’s embolization portfolio.

The company shared that the Sendero Max uses a hydrophilic coating, stainless steel braid, and radiopaque marker band to optimize trackability and enable precise placement of interventional devices. An inner PTFE (polytetrafluoroethylene) liner also allows for low-friction delivery of interventional devices.

Okami noted that their embolization portfolio, which is composed of Sendero catheters and Lobo occluders, provides physicians with a versatile solution for obstructing blood flow in 1.5- to 9-mm peripheral arterial vessels.

“I've successfully used the Sendero Microcatheter to deliver Lobo-3 and Lobo-5 and am looking forward to the addition of Sendero& Max to deliver Lobo-7 and Lobo-9,” commented Nima Kokabi, MD, in the company’s announcement. “With the expanded Sendero portfolio, we can move beyond the limitations of traditional coils and vascular plugs, so we can confidently, predictably, and rapidly treat our patients in a wide range of cases.”

Dr. Kokabi is an interventional radiologist at the University of North Carolina in Chapel Hill, North Carolina.